Proteins and Peptides
11 November 2014
Synageva BioPharma Presents New Data From Phase 3 Study Of Sebelipase Alfa In Children And Adults With LAL Deficiency At The AASLD Meeting4 November 2014
D-Pharm reports first results from its Phase 2 clinical study of THR-18 in acute stroke patients treated with tPA3 November 2014
Eleven Biotherapeutics Completes Enrollment in Pivotal Phase 3 Study of EBI-005 in Patients with Dry Eye Disease3 November 2014
Nymox NX-1207 BPH Pivotal Phase 3 U.S. Studies NX02-0017 and NX02-0018 Fail to Meet Primary Efficacy Endpoints28 October 2014
Apogenix – Positive Results from APG101 Phase II Clinical Trial Published in Clinical Cancer Research28 October 2014
PROMETIC LIFE SCIENCES INC. PROMETIC’S PLASMINOGEN IND AND CLINICAL PROGRAM CLEARED BY FDA24 October 2014
Rhythm Presents Positive Phase 2 Study Results for Relamorelin for Chronic Constipation24 October 2014
FDA Approves Baxter’s OBIZUR [Antihemophilic Factor (Recombinant), Porcine Sequence], for Acquired Hemophilia A22 October 2014
Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes22 October 2014
Synageva BioPharma Starts Rolling Submission Of A Biologics License Application To The FDA For Sebelipase Alfa20 October 2014
Genervon Announces ALS and PD Phase 2a Trial Results17 October 2014
China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility16 October 2014
Allegro Ophthalmics Begins Phase 2 Clinical Trial of Luminate® (ALG-1001) for the Treatment of Diabetic Macular Edema10 October 2014
FDA Approves VELCADE® (bortezomib) for Injection for Previously Untreated Patients with Mantle Cell Lymphoma10 October 2014
ORBACTIVTM (Oritavancin) Phase 3 SOLO II Trial Results Published in the Journal Clinical Infectious Diseases9 October 2014
N8 Respiratory Presents Data Demonstrating Antimicrobial Efficacy of CSA-13 Against Psuedomonas Aeruginosa Biofilm8 October 2014
Trevena Announces Early Completion of Enrollment of Phase 2a/b Study of TRV130 in Postoperative PainNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports